The approved product is a generic version of Genzyme Corporation's Renagel tablets.

"There is a fresh wave of consolidation expected next year that could trigger another wave of price erosion."

Clinton is generally perceived to be negative for pharma companies on the premise that she would try to curb the profits earned by drug fir...

The global investment bank highlights Lupin as the top pick in the Indian pharma sector.

Global brokerage firms have maintained either buy or outperform ratings on the following five stocks after these companies announced earnin...

Every decade has produced a new set of Thalaivas in the Indian market. They all started at the bottom and are now in the league of India’s ...

Analysts say the domestic market has turned a fertile ground for stock picking and going for stocks with earnings visibility can prove good...

'We do expect nicotinic acid and Aspen to be launched by the end of this quarter,' says Ramesh Swaminathan.

The stock has extended overnight gains after the company reported a Q4 net profit of Rs 408 crore, up 161 pc YoY.